India Bans Key Antibiotics in Food Production: A Bold Move Against Superbugs
In a landmark public health decision, the Indian government has banned the use of critical antibiotics, including colistin, in food production—marking a significant shift in its strategy to combat antimicrobial resistance (AMR). The ban applies to the use of these drugs in the production of meat, poultry, and dairy products, and signals a serious commitment to tackling what experts warn is a looming global health crisis.
AMR occurs when bacteria evolve to resist the effects of antibiotics, making once-effective treatments useless. Over time, this could render common infections untreatable, potentially undoing decades of medical progress. One of the biggest contributors to AMR is the misuse and overuse of antibiotics—not just in human medicine, but also in livestock farming. India has long been criticized for lax controls over antibiotic use in the animal agriculture sector, where drugs are often used not only to treat disease but also to promote growth in unsanitary conditions.
The Ministry of Health and Family Welfare, in coordination with the Ministry of Fisheries, Animal Husbandry and Dairying, has taken this major step to close a dangerous loophole. While colistin had already been banned in agriculture in 2019, enforcement was weak. It continued to be used, especially via feed premixes in poultry farming. The new regulation now fully prohibits its manufacture, sale, and distribution for use in food-producing animals.
Colistin, once dubbed a “last-resort” antibiotic, is commonly used in intensive care units to treat life-threatening infections when other antibiotics fail. Its overuse in animal agriculture—where it was routinely mixed into animal feed—has led to growing resistance, making it less effective even in clinical settings. A 2017 study shocked the global health community by discovering colistin-resistant bacteria in chicken and meat samples in India, along with genes linked to resistance in humans and environmental samples.
India’s expanded ban is being widely hailed by scientists and public health experts as a much-needed step toward protecting the future efficacy of antibiotics. By clamping down on such misuse, India aligns itself with the World Health Organization’s “One Health” approach, which emphasizes the interconnectedness of human, animal, and environmental health.
However, the success of this move hinges on proper enforcement. The Indian poultry and dairy sectors remain largely unregulated, with many small-scale farmers relying heavily on low-cost antibiotics to meet rising consumer demand. Veterinary antibiotics are often dispensed without prescriptions or oversight, due in part to lack of awareness and infrastructure.
Experts caution that without strict monitoring, education campaigns, and support for farmers to adopt safer, antibiotic-free practices, the new regulation may fall short of its intended impact. Still, India’s decision sets a powerful precedent and could inspire similar actions globally.
With superbugs posing an existential threat to modern medicine, this decisive action may prove pivotal in steering the country—and potentially the world—toward a more responsible and sustainable future in antibiotic use.
IT.
